ArticleThe breast journal2026
Rising Breast Cancer Incidence and Poor Outcomes in Young Women: A Retrospective Study.
Article in The breast journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rising Breast Cancer Incidence and Poor Outcomes in Young Women: A Retrospective Study.The breast journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Recent studies suggest a rise in breast cancer (BC) among young women. We analyzed BC incidence patterns among women aged 18-40 in the TriNetX network from 2014 to 2023, stratifying by age, race, and ethnicity. We also examined mortality and local recurrence (LR) in women aged 18-40 diagnosed with primary BC. Methods: This retrospective study used data from the TriNetX network. Female patients aged 18-40 were identified, and the incidence proportion of primary BC from 2014 to 2023 was assessed using the TriNetX Incidence and Prevalence Analytics function, with stratification by age, ethnicity, and race. A second cohort of women aged 18-40 with a primary BC diagnosis was created to evaluate mortality and LR over the same period. All analyses were descriptive. Results: Among the 18,250,987 women aged 18-40 years in the TriNetX network, the incidence proportion of BC increased from 635 cases in 2014 to 4475 in 2023. White women accounted for the greatest number of BC cases; however, increasing incidence proportions were also observed among American Indian/Alaskan Native (AI/AN), Asian, and Native Hawaiian/Pacific Islanders (NHPIs) women over the last four years. Non-Hispanic women initially had higher incidence proportions but were surpassed by Hispanic women in 2022. Among 38,683 women aged 18-40 with primary BC, both mortality (0.09%-0.851%) and LR (0.3%-2.9%) increased over the study period. Conclusion: Within the TriNetX network, BC incidence proportion among women aged 18-40 demonstrated an upward trend from 2014 to 2023, particularly among non-Hispanic White women 30-39 years old. An uptrend was also seen in young AI/AN, Asian, NHPI, and Hispanic women. In addition, increased documented mortality and LR were also observed. These findings underscore the importance of further research to understand these trends and develop diagnostic and therapeutic approaches tailored to younger patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.